Evommune, Inc. Common Stock Aktie - Unternehmensdaten & Kurse - US30054Y1073 | goSPATZ

Evommune, Inc. Common Stock

Share · US30054Y1073 · EVMN (XNYS)

No Price

12.12.2025 20:59

Current Prices from Evommune, Inc. Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NYSE	EVMN	USD	12.12.2025 20:59	18,01 USD	-1,69 USD -8,56 %

Share Float & Liquidity

Free Float 97,48 %

Shares Float 12,55 M

Shares Outstanding 12,87 M

Company Profile for Evommune, Inc. Common Stock Share

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. It develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products includes EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.

Get up to date insights from finAgent about Evommune, Inc. Common Stock

Company Data

Name Evommune, Inc. Common Stock

Company Evommune, Inc.

Symbol EVMN

Website https://www.evommune.com

Primary Exchange

NYSE

ISIN US30054Y1073

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Luis C. Pena

Market Capitalization 238 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 1841 Page Mill Road, 94304 Palo Alto

IPO Date 2025-11-06

Ticker Symbols

Name	Symbol
NYSE	EVMN

More Shares

Investors who hold Evommune, Inc. Common Stock also have the following shares in their portfolio:

Cebu Air, Inc. Depository Receipt

DZ BANK IS.A1808 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025